Observational studyFuture oncology (London, England)2024

Real-world experience of second-line axitinib in metastatic renal cell carcinoma: analysis of the Swedish population.

Maria Jakobsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.